| HBS Case Collection
(Revised from original 2006 version)
Endo Pharmaceuticals (C): An "At Risk" Launch?
Keywords: Product Launch;
Risk and Uncertainty;
Hamermesh, Richard G., and Brian DeLacey. Endo Pharmaceuticals (C): An "At Risk" Launch? Harvard Business School Supplement 806-066, May 2007. (Revised from original January 2006 version.)